Skip to main content
Clinical Trials/NCT01817491
NCT01817491
Completed
Not Applicable

Low Fat Vegan Diet or American Heart Association Diet, Impact on Biomarkers of Inflammation, Oxidative Stress and Cardiovascular Risk in Obese 9-18 y.o. With Elevated Cholesterol: A Four Week Randomized Trial

The Cleveland Clinic1 site in 1 country60 target enrollmentMarch 2013

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Cardiovascular Disease
Sponsor
The Cleveland Clinic
Enrollment
60
Locations
1
Primary Endpoint
Change in Circumference
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

The purpose of this study is to investigate the short-term effects of a reduced fat plant-based diet on biomarkers of inflammation, oxidative stress and cardiovascular risk. This plant-based diet consists of whole grains, fruits and vegetables and little amounts of nuts and seeds, with no limitations on the amount of food intake. Animal products are not allowed. The results of the plant-based diet will be compared with the diet recommended by American Heart Association. This diet also emphasizes fruits and vegetables, but allows healthy fats, low-fat meats, fish and low-fat dairy in moderation. The results of the study might be useful in understanding whether or not plant-based diets are protective against cardiovascular disease.

Detailed Description

Scientific Question: In obese, hypercholesterolemic (\>169 mg/dl) 9-18 year olds and one of their parents are biomarkers of inflammation, oxidative stress and cardiovascular risk significantly reduced after a randomized 4 week trial of a reduced fat, vegan diet, or the American Heart Association (AHA) diet (which also encourages fruits, vegetables and whole grains, but permits low fat meat and dairy, and fish)? Rationale: "Cardiovascular disease remains the leading cause of death in North Americans, but manifest disease in childhood and adolescence is rare. By contrast, risk factors and risk behaviors that accelerate the development of atherosclerosis begin in childhood, and there is increasing evidence that risk reduction delays progression toward clinical disease". Myeloperoxidase is an early biomarker of inflammation, oxidative stress and cardiovascular risk in prepubertal obese children and is over expressed in children with hypercholesterolemia. Trimethylamine N-oxide, global arginine bioavailability ratio, arginine methylation index, paraoxonase 1 gene, and F2-isoprostane are all also associated with future major adverse cardiovascular events. Studies have suggested that a low-fat, vegan diet is effective in promoting weight loss, lowering body mass index, improving lipoprotein profiles, insulin sensitivity and in preventing cardiovascular disease in overweight individuals. Vegetarian diets have been shown to not only prevent but also to reverse heart disease in adults. Dietary habits (e.g. vegan/vegetarian versus omnivore/carnivore) are associated with significant alterations in intestinal microbiota composition and function. The diet-microbe interaction may play a significant role in the cardiovascular protective effects of a vegan/vegetarian diet. One small report of 15 adults on a reduced fat, vegan "Engine 2 Diet" for four weeks reported decreases in mean total cholesterol from 197 mg/dl to 135 mg/dl and mean LDL cholesterol falling from 124 mg/dl to 74 mg/dl. Innovation: This is the first randomized trial comparing a low fat vegan diet to the standard AHA diet. If one diet proves superior in this brief pilot study, future larger long term studies will be needed to clearly define the health implications of our results. Methods: Obese hypercholesterolemic children ages 9-18 will be identified by reviewing medical records and recruited initially by letters. Child, parent/guardian pairs will be randomly assigned to either the reduced fat vegan diet or the AHA diet. During the 4-week study, participants will be asked to attend a group teaching and cooking session once a week on Saturday to learn about their assigned diets. The participants will also be requested to record their diet history on 2 weekdays and 1 weekend day before and again during the 4 weeks of the study.

Registry
clinicaltrials.gov
Start Date
March 2013
End Date
December 2014
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

michael macknin

Professor of Pediatrics Cleveland Clinic Lerner College of Medicine of Case Western Reserve

The Cleveland Clinic

Eligibility Criteria

Inclusion Criteria

  • Children ages 9-18
  • BMI \> 95th percentile
  • Hypercholesterolemia (\>169 mg/dl)

Exclusion Criteria

  • Pregnant women
  • Patients already on vegetarian diets

Outcomes

Primary Outcomes

Change in Circumference

Time Frame: baseline, 4 weeks

Change in Liver Enzymes

Time Frame: baseline, 4 weeks

Change in Lipid Profile

Time Frame: baseline, 4 weeks

Change in Weight

Time Frame: baseline, 4 weeks

Change in Glucose

Time Frame: baseline, 4 weeks

Change in Blood Pressure (BP)

Time Frame: baseline, 4 weeks

Change in IL-6 (Interleukin-6)

Time Frame: baseline, 4 weeks

Change in MPO (Myeloperoxidase)

Time Frame: baseline, 4 weeks

Children Change in BMI Z Score

Time Frame: baseline, 4 weeks

Body mass index z-scores, also called BMI standard deviation (s.d.) scores, are measures of relative weight adjusted for child age and sex. Given a child's age, sex, BMI, and an appropriate reference standard, a BMI z-score (or its equivalent BMI-for-age percentile) can be determined. Negative BMI z-scores indicate a BMI that is lower than the population mean, while positive BMI scores indicate a value that is higher than the population mean. A decrease in the BMI z-score over time indicate a lowering of the BMI. Z-scores of 1.03 and 1.64 correspond to the 85th and 95th percentiles of BMI-for-age, which are the definitions of overweight and obesity in children.

Change in HgbA1c (Hemoglobin A1c)

Time Frame: baseline, 4 weeks

Change in Body Mass Index BMI Percentile

Time Frame: baseline, 4 weeks

Change in PAQ (Physical Activity Questionnaire)

Time Frame: baseline, 4 weeks

PAQ self reported questions based on activity level from 1 (low activity) to 5 (high activity), overall PAQ score is a mean of the questions.

Change in hsCRP (High-sensitivity C-reactive Protein)

Time Frame: baseline, 4 weeks

Change in Insulin

Time Frame: baseline, 4 weeks

Secondary Outcomes

  • PB/AHA - Adjusted Mean Difference PAQ Children(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Lipid Profile(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Difference BMI(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Ratio MPO(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Ratio HgbA1c(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Difference Circumference(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Difference Weight(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Ratio Glucose(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Ratio Liver Enzymes(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Difference BMI Z Score Children(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Ratio hsCRP(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean BP(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Ratio IL-6(Baseline, 4 weeks)
  • PB/AHA - Adjusted Mean Ratio Insulin(Baseline, 4 weeks)

Study Sites (1)

Loading locations...

Similar Trials